Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Market Access
Global Capabilities, Local Specialists
Increasing cost constraints, rapidly evolving policy environments (e.g., IRA, HTA changes, orphan drug legislation, and more), and increased competition are driving great complexity in the market access environment. Our Market Access teams help clients navigate this environment with confidence. As a trusted guide, we bring robust market access experience, finely tuned instincts, and deep expertise with local market requirements.
- Dedicated global team with expertise in all major market regions
- Robust network of payers, organized customers, and access influencers helps drive primary research and inform strategy development
- Integrated market access strategy and support throughout the product lifecycle
- Alignment and integration with Medical and Commercial strategies
- Global, regional, and local coordination to ensure launch readiness
- Seamless integration throughout the market access journey, from insight generation to strategy development to customer engagement
Services
- Insights
Understand how market access stakeholders’ needs and perspectives will affect your asset specifically.
Market Assessment
-
- Patient Access Journey
- Site of Care Assessment
- Target Product Profile (TPP) Assessment
- Value Chain Ecosystem Analysis (US)
- HTA Landscape / Payer & Market Archetyping (EU/ROW)
- Reimbursement Pathway / Funding
- Health Equity Landscape Assessment
- Health Policy Impact
Competitive Assessment
-
- Competitive Threat Assessment
- Biosimilar / Generic Entry Assessment
- Competitive Simulation Workshops
-
- Strategy
Determine how to optimize access through pricing, evidence, and value throughout the life cycle.
Market Access Strategic Planning
-
- Global Market Access Strategy, Launch Plan & Roadmap
- Access-Rationalized Pipeline Strategy / Indication Sequencing
- Access Objective & Metric Setting (US)
- Targeting, Segmentation, & Archetyping (US)
Access Evidence Strategy
-
- Access-Enabled TPP Development
- TPP / Value Driver Assessment
- Payer-Rationalized Trial Design
- Access Evidence Planning
Pricing & Contracting Strategy
-
- Launch Price Analysis & Strategy
- Region / Market / Segment Net Price & Managed Entry / Contracting
- GTN Impact Analysis
- Competitive Impact Simulation
- Global Pricing Strategy
Patient Services & Reimbursement Support
-
- Hub & Co-Pay Support Strategy (US)
- Field Reimbursement Support Strategy (US)
- Foundation Strategy (US)
-
- Customer Engagement
Identify the best ways to engage with market access stakeholders and communicate value.
Customer Engagement Tactics
-
- Value Proposition Development
- Payer Objection Handling
- Mock Negotiation Training (EU/ROW)
- PIE & Post-Approval Value Message Testing (US)
- Customer Engagement Planning (US)
- Health Equity Solutions
Customer Engagement Execution Support
-
- Salesforce Learning & Development
- Stakeholder-Facing Materials
- Digital Provider Engagement
-
Thought Leadership
The Joint Clinical Assessment: Expectations and Strategic Implications
January 22, 2025
Surveying the Shifting Landscape in European Market Access (Part 3: The JCA – Expectations and Strategic Implications)
January 07, 2025
